10i M for relaxation of carbachol induced contractions, whereas concentrations of 10'-10-M or greater were required to relax contractions induced by allergen and nine other non-muscarinic mediators. It is suggested that bronchodilatation by antimuscarinic drugs in vivo is due to inhibition of acetylcholine induced bronchoconstriction alone and that beta2 agonists and xanthines have poor ability to protect airway smooth muscle against constrictor stimuli. Hence mechanisms other than bronchodilatation and "functional antagonism" should be considered to explain the protection against constrictor stimuli in asthma seen with beta2 agonists and xanthines.
Three classes of drugs, beta2 agonists, xanthines, and antimuscarinics, are known to produce acute bronchodilatation in asthmatic patients. Pharmacological antagonism of muscarinic contraction by antimuscarinic drugs has been amply documented in vitro and in vivo,' but the specificity of action of these drugs against non-muscarinic contractile mediators has not been assessed to any extent. The present study has examined the specificity of muscarinic antagonism by atropine sulphate, ipratropium bromide, and glycopyrrolate in tracheal preparations in vitro against 10 different contractile mediators and allergen. Xanthines and beta2 receptor agonists are frequently described as functional mediator antagonists because they relax airway smooth muscle irrespective of the mediator or mediators that caused contraction. 3 Physiological or functional antagonism has also been the favoured explanation for the protection offered by these drugs against provoked bronchoconstriction in asthmatic subjects,2' but this has not yet been shown experimentally. Possibly the pharmacology of relaxation is distinct from that of anticonstrictor effects. Indeed, the protective effects of beta2 agonists and xanthines in asthma might conceivably result from an effect on cells other than smooth muscle.101' The present study has examined the effect of xanthines and terbutaline on carbachol and histamine induced contraction of guinea pig tracheal preparations, looking at concentrations that produce pronounced relaxant effects in vitro.12-14 These drug concentrations are above (about 5-10 times) the blood concentrations seen with systemic treatment (with xanthines and terbutaline), though a similar concentration of terbutaline may be reached in airway smooth muscle tissue after inhalation.
Methods

AIRWAY SMOOTH MUSCLE PREPARATIONS
Male guinea pigs, weighing 200-300 g, were killed by a blow to the head, and the trachea was dissected out. Two adjoining cartilage rings were cut out and an open tracheal ring was prepared by cutting through the cartilage opposite the muscle. This technique preserves the epithelial lining.'3 The presence or absence of epithelium is of little or no consequence for the development of spontaneous tension in these preparations'3 or for determining the relaxant potencies of beta2 agonists and xanthines. 13 The open tracheal ring was mounted in a jacketed, temperature controlled (37'C), 25 ml organ bath containing Krebs's solution of the following composition (mM): NaCl 118 0, KC1 4-6, CaC12 2-5, MgSO4 1-15, NaHCO3 24-9, KH2PO4 1 15, and glucose 5 5 with a pH of 7 4 and aerated with 5% carbon dioxide in oxygen. Change in muscle tension was measured isometrically by a strain gauge transducer (Grass FT03) and recorded on a Grass polygraph (model 7D). The initial mounting tension was adjusted to around 0-5 g. Prepara-tions were allowed to stabilise for at least 30 minutes with repeated washings. Drugs were added by injection into the organ baths.
MEASUREMENT OF DRUG EFFECTS
Theophylline, enprofylline, and terbutaline These experiments were carried out in the presence of indomethacin (1 x 10 M) to reduce spontaneous tension so that near maximal to slightly supramaximal relaxant effects could be produced by the beta2 agonist and xanthines (the results are similar in the absence of indomethacin; data not shown).
A cumulative concentration-response relationship for carbachol was obtained by increasing the concentration (10-10-3 M) in the bath stepwise until no further response occurred with two consecutive concentrations. The trachea was then washed. Two carbachol concentration-response studies were performed with each preparation to confirm repeatability. It was then treated with one of the following: theophylline 2-2 x 10-or 4-4 x 10 M, enprofylline 5-2 x 10-5or 1 0 x 10 M, or terbutaline Il1 x 10-7or 2-2 x IO7M (these concentrations are known to produce maximal or near maximal relaxant effects in intrinsic tension tracheal ring preparations 213 
SOURCE AND PREPARATION OF DRUGS
Indomethacin, carbamylcholine chloride (carbachol), ovalbumin grade III, 5-hydroxytryptamine (serotonin), bradykinin, lysbradykinin, met-lys-bradykinin, and atropine sulphate were obtained from Sigma Chemicals, USA. Terbutaline sulphate, theophylline, and enprofylline were obtained from Draco, Lund, Sweden; leukotriene C4 and leukotriene D4 from Miles Scientific, USA; histamine dihydrochloride from ACO, Sweden; prostaglandin F2, (Amoglandin) from Kabi Vitrum, Sweden; substance P from Peninsula Laboratories, England; ipratropium bromide (Atrovent) from Boehringer Ingelheim, Germany; and glycopyrrolate (AHR-504) from A H Robins, England.
Indomethacin was dissolved in 5% NaHCO3 before dilution with 09% NaCl. Leukotriene C4 and D4 were dissolved in 70% ethanol before dilution with phosphate buffer (pH 6 9). All other drugs were diluted with saline.
ANALYSIS
The maximal changes in tension induced by the xanthines, terbutaline, carbachol, and his- Indomethacin significantly reduced spontaneous basal tension in the tracheal ring preparations before carbachol (n = 36) and histamine (n = 30) (initial tension: 10 9 (0 5) and (0-4) mN; after indomethacin: 9.3 (0-4) and 11 4(0 5)mN(p < 0-001)). TheEC50 value for the carbachol concentration-response study in the absence of indomethacin (5-3 x 10-7 M) was less than in its presence (2-4 x 104 M; p < 0-001), but the maximally induced tension was not altered (data not shown; p = 0-76, n = 72). terbutaline produced any shift of the carbachol concentration-response line (fig 1) . The presence of xanthines or terbutaline did not reduce the maximal tension induced by carbachol. Hence the difference between the lowest (starting tension) and the highest (maximal) tension for the carbachol contraction was larger when carbachol was added to tracheal rings that had been relaxed by a bronchodilator than when it was added to the control preparations (p < 0-001, n = 54). Consequently the EC,0 values of carbachol given in table 1 are not directly comparable.
Indeed, an unchanged EC5s value suggests that the carbachol induced increase in tension is slightly greater in the presence of a bronchodilator than that observed with the same concentration of carbachol in the absence of the bronchodilator.
EFFECTS OF THEOPHYLLINE AND TERBUTALINE
ON HISTAMINE CONTRACTION
Both terbutaline 1-1 x IO`M and theophylline 2-2 x 10' M caused relaxation of basal tension (by 6-7% (2-3%) and 23-3% (6-7%), n = 12). The initial histamine concentration-response line was further to the left than the second (p < 0-001) and the third (p < 0-05) lines; the latter two lines did not differ (fig 2, table 2 ). The second line was used as the control for subsequent comparisons. Neither theophylline nor terbutaline produced any significant shift ofthe histamine concentration-response line (fig 2) . - [6] > 1 x IOA [6] 3-5 x 1ICr5(0-6) [8] SubstanceP - [6] > 1 x 103 [5] 1-1 x 10-'(1-1) [5] Leukotriene C4
- [8] > 1 x 104 [7] 2-9 x 10-'(0-4) [5] LeukotrieneD4 - [8] > 1 x 10-3 [8] 3-1 x 10' (0-6) [5] Ovalbumin - [6] > 1 x 1IV [12] 5-2 x 10-'(1-9) [5] Bradykinin - [12] > 1 x 10-3 [10] 3-2 x 1I-(1-0) [9] Lys-bradykinin - [6] > 1 x 10-4 [6] 3-6 x 10-5 (0-9) [5] Met-lys-bradykinin
The maximal tension induced by histamine was not reduced by theophylline or terbutaline (p > 0-05, analysis of variance). The difference between starting tension and maximal histamine induced contraction was therefore larger when histamine was added to tracheal rings that had been relaxed by terbutaline or theophylline than when it was added to control preparations (p < 0-001).
EFFECTS OF ATROPINE SULPHATE, IPRATROPIUM BROMIDE, AND GLYCOPYRROLATE
The tracheal ring preparations had a mean tension of 9-0 (0-2) mN before administration of drug. Addition of contractile mediators increased the tension to at least 13-7 (0-5) mN Atropine sulphate, ipratropium bromide, and glycopyrrolate had no effect on the spontaneous tension of untreated preparations given at concentrations below 1 x 104 M (concentrations above 1 x 10A M produced slight contractions). All three drugs caused pronounced relaxation in preparations precontracted with carbachol. The EC50 values for carbachol contracted trachea were more than 100 times lower than those obtained with the next most effective mediator (table 3) .
Discussion
The concentration-response characteristics, including the maximally induced tension, of a muscarinic agonist, carbachol, and histamine were not affected, or were only marginally and inconsistently affected, by the presence oftheophylline, enprofylline, or terbutaline. The main effect of relaxation induced by these bronchodilators was to allow carbachol and histamine to cause contraction over a wider tension range. These data suggest that xanthines and beta2 receptor agonists may not exert a prophylactic effect at the level of airway smooth muscle. These drugs may be functional antagonists when they relax contracted preparations3 but, in the concentrations studied, appear to be without functional antagonism against the initiation and development of airway contraction.
Supramaximal relaxant concentrations of beta2 agonists in the airways may protect airway smooth muscle, but whether such concentrations are obtained after inhalation of beta2 agonists remains to be shown. The concentration of these drugs is probably much larger on the mucosal surface and in the lamina propria than around the smooth muscle as this is deeper in the airway wall. Before reaching the muscle in vivo an inhaled drug has to pass an abundant and extensively perfused microvascular network located just beneath the epithelial lining.
Adenosine was not included in this study because it may not contract the preparations we used.'3 Adenosine, however, contracts human airway smooth muscle. Theophylline acts on adenosine receptors as a specific antagonist. 15
Enprofylline, in line with its general lack of adenosine antagonism, does not shift the contractile effect of adenosine in human bronchi.'0
The particular ability of theophylline to exert a protective effect through adenosine antagonism may not be important. The similar clinical efficacy of enprofylline and theophylline suggests that adenosine antagonism is of little consequence in asthmatic airways. ' The tension of guinea pig tracheal preparations in vitro has not been fully explained3 2but is reduced by indomethacin, a drug that inhibits the generation of arachidonate metabolites of the cyclo-oxygenase pathway.'323 Indomethacin reduced spontaneous tension. The further relaxant effects of xanthines and terbutaline appeared to be maximal for theophylline and enprofylline and near maximal for the partial agonist terbutaline. These data are consistent with previous observations on the potency of beta agonists and xanthines in vitro."2-4 The ECs0 of carbachol was increased by indomethacin. Indomethacin has been associated with reduced sensitivity to several contractile agents in guinea pig trachea2324 and, less consistently, in human bronchi in vitro" and in vivo.26
Ipratropium bromide, glycopyrrolate, and atropine sulphate did not interact significantly with any mediator other than the muscarinic agonist. The three antimuscarinic drugs caused substantial antagonism of carbachol with a selectivity ratio by comparison with other mediators of at least 102. With ipratropium bromide the ratio was more than 103. The small interactions that occurred with other mediators are probably of little interest as such concentrations are unlikely to be seen even with large inhaled doses. These data support the view that antimuscarinic drugs antagonise only acetylcholine induced bronchoconstriction in asthma.'
The subcellular mechanisms leading to the initiation of contraction differ from those concerned in the maintenance of an established contraction.27 As xanthines and beta2 agonists reduce established contractions and antimuscarinic drugs inhibit one mediator only, a search for drugs that inhibit the initiation and development ofairway smooth muscle contractions may be warranted. 
